Think Research Announces Approximately $12.8 Million of New BioPharma Contracts Signed During Q3 2022
Revenue recognition commencing in September to October timeframe. Average length of each program is approximately 12 months. TORONTO, ON – September 20, 2022 – Think Research Corporation (TSX.V:THNK)